Published in
Springer Verlag, Neurotherapeutics, 1(15), p. 178-189
DOI: 10.1007/s13311-017-0572-5
Links
Tools
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
Journal article published in 2017 by
Jordi Bruna,
Sebastián Videla,
Andreas A. Argyriou,
Roser Velasco,
Jesús Villoria,
Cristina Santos,
Cristina Nadal,
Guido Cavaletti,
Paola Alberti 
,
Chiara Briani,
Haralabos P. Kalofonos,
Diego Cortinovis,
Mariano Sust,
Anna Vaqué,
Thomas Klein
and other authors.
,
Chiara Briani,
Haralabos P. Kalofonos,
Diego Cortinovis,
Mariano Sust,
Anna Vaqué,
Thomas Klein
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 